You are here

  • Home
  • Archive
  • Volume 39, Issue 3
  • Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings

Article info

Article menu
Download PDFPDF
Letters to the editor
Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings

Authors

View Full Text

Citation

Chlebowski RT, Nikolaenko L, Anderson G
Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings
Journal of Family Planning and Reproductive Health Care 2013;39:226-228.

Publication history

  • First published June 18, 2013.
Online issue publication 
May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions